Skip to main content
Caplight Logo









RebrAIn

RebrAIn

Private
BordeauxHealthcare & Life Scienceshttps://rebrain.eu/

Last Round

Seed

Mar 18, 2024

Total Funding Raised

$4.4M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RebrAIn is a medical technology company that provides a precise targeting technology for helping with surgical treatments of neurodegenerative diseases.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Medical Devices, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

neurosurgical planningdeep brain stimulationDBSsoftware as a medical deviceSaMDsurgical navigationmedical imagingsurgical AIdigital twinfunctional neurosurgerylesioningmovement disorderssurgical planning softwarebrain mappingneurosurgery tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

RebrAIn Comparables

Compare RebrAIn with similar companies based on industry and business-model similarity.

RebrAIn comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Omniscient Neurotechnology
77%
Augmedit
75%
Zeta Surgical
75%

RebrAIn Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedMar 18, 2024
Pre SeedApr 1, 2020

RebrAIn Investors

Notable investors and investment history

RebrAIn investors
InvestorRounds
Nouvelle-Aquitaine Co-investissementSeed
KaristaSeed
Aquitaine Science TransfertPre Seed, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 53% MoM.

  • Mar 18, 2024

    $4M round led by Karista.

Recent news

Latest coverage and updates

  • attends_eventSep 17, 2026

    Rebrain will attend event WSSFN 2026 on Sep 30th '26.

RebrAIn Filings

Explore SEC and related filing metadata, where available.

RebrAIn filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about RebrAIn's valuation, stock price, and market status.

Is RebrAIn a public or private company?

RebrAIn is a private company.

What is the current stock price of RebrAIn?

RebrAIn is a private company with no public stock price. No recent secondary market data is available.

How much is RebrAIn worth (valuation)?

Valuation information for RebrAIn is not publicly available.

Can I buy RebrAIn stock?

RebrAIn shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was RebrAIn's last funding round?

RebrAIn's most recent funding round was Seed on March 18, 2024.

Who are the main investors in RebrAIn?

Key investors in RebrAIn include Karista.

Will RebrAIn IPO soon?

No public IPO plans have been announced for RebrAIn.

How can I track RebrAIn secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor RebrAIn's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBordeaux
Employee Range14
Year Founded2021
Last FundingMar 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?